Capsular Tension Ring Implantation for Intraocular Lens Power Calculation in Highly Myopic Eyes: Secondary Analysis of a Randomized Clinical Trial.

IF 7.8 1区 医学 Q1 OPHTHALMOLOGY
Haowen Lin, Jiaqing Zhang, Aixia Jin, Yifan Zhang, Yu Zhang, Ling Jin, Yifan Xu, Xiaohang Xie, Xiaozhang Qiu, Boyufei Dai, Xuhua Tan, Lixia Luo, Yizhi Liu
{"title":"Capsular Tension Ring Implantation for Intraocular Lens Power Calculation in Highly Myopic Eyes: Secondary Analysis of a Randomized Clinical Trial.","authors":"Haowen Lin, Jiaqing Zhang, Aixia Jin, Yifan Zhang, Yu Zhang, Ling Jin, Yifan Xu, Xiaohang Xie, Xiaozhang Qiu, Boyufei Dai, Xuhua Tan, Lixia Luo, Yizhi Liu","doi":"10.1001/jamaophthalmol.2025.0110","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Capsular tension ring (CTR) implantation has been shown to reduce intraocular lens (IOL) decentration and tilt in high myopia. However, the effect of CTR implantation in highly myopic eyes on IOL power calculation remains unclear, particularly in new-generation formulas.</p><p><strong>Objective: </strong>To evaluate the influence of CTR implantation on IOL power calculation in highly myopic eyes.</p><p><strong>Design, setting, and participants: </strong>This is a prespecified secondary analysis of outcomes of a randomized clinical trial conducted between November 2021 and September 2023 at the Zhongshan Ophthalmic Center in Guangzhou, China. Cataract patients with an axial length (AL) of 26 mm or longer were enrolled and stratified into 3 strata based on AL (stratum 1: AL 26-<28 mm; stratum 2: AL 28-<30 mm; stratum 3: AL ≥30 mm).</p><p><strong>Interventions: </strong>Participants were stratified based on AL and randomized to the CTR group (a C-loop IOL combined with a CTR) or the control group (only a C-loop IOL) within each stratum.</p><p><strong>Main outcomes and measures: </strong>Predictive outcomes of 6 new-generation formulas and 4 traditional formulas were evaluated. The arithmetic and absolute prediction error (PE) and the percentages of eyes within ±0.25 diopter (D), ±0.50 D, ±0.75 D, and ±1.00 D of PE were analyzed.</p><p><strong>Results: </strong>A total of 186 eyes of 186 participants were randomized into the CTR group (93 eyes [50%]) or control group (93 eyes [50%]). Excluding a withdrawal case and 24 eyes with best-corrected visual acuity less than 20/40, 80 eyes in the CTR group (86.0%) and 81 eyes in the control group (87.1%) were analyzed. Of 161 participants analyzed, overall mean (SD) participant age was 56.7 (10.5) years, and 100 participants (62.1%) were female. No differences were observed in arithmetic PE between the CTR and control groups in any strata. The CTR group showed smaller absolute PE in all new-generation formulas and higher percentage of PE within ±0.50 D in the Emmetropia Verifying Optical 2.0, Hoffer QST, LISA, and Pearl-DGS formulas only for eyes with an AL of 30 mm or longer compared with the control group. In traditional formulas, no differences were observed between the 2 groups in any strata.</p><p><strong>Conclusions and relevance: </strong>In this secondary analysis, CTR implantation in highly myopic eyes did not affect the target refraction and can improve the prediction accuracy of new-generation IOL calculation formulas in eyes with AL of 30 mm or longer. These findings support use of CTR implantation in eyes with an AL of 30 mm or longer.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT05161520.</p>","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"373-381"},"PeriodicalIF":7.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11926735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaophthalmol.2025.0110","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Capsular tension ring (CTR) implantation has been shown to reduce intraocular lens (IOL) decentration and tilt in high myopia. However, the effect of CTR implantation in highly myopic eyes on IOL power calculation remains unclear, particularly in new-generation formulas.

Objective: To evaluate the influence of CTR implantation on IOL power calculation in highly myopic eyes.

Design, setting, and participants: This is a prespecified secondary analysis of outcomes of a randomized clinical trial conducted between November 2021 and September 2023 at the Zhongshan Ophthalmic Center in Guangzhou, China. Cataract patients with an axial length (AL) of 26 mm or longer were enrolled and stratified into 3 strata based on AL (stratum 1: AL 26-<28 mm; stratum 2: AL 28-<30 mm; stratum 3: AL ≥30 mm).

Interventions: Participants were stratified based on AL and randomized to the CTR group (a C-loop IOL combined with a CTR) or the control group (only a C-loop IOL) within each stratum.

Main outcomes and measures: Predictive outcomes of 6 new-generation formulas and 4 traditional formulas were evaluated. The arithmetic and absolute prediction error (PE) and the percentages of eyes within ±0.25 diopter (D), ±0.50 D, ±0.75 D, and ±1.00 D of PE were analyzed.

Results: A total of 186 eyes of 186 participants were randomized into the CTR group (93 eyes [50%]) or control group (93 eyes [50%]). Excluding a withdrawal case and 24 eyes with best-corrected visual acuity less than 20/40, 80 eyes in the CTR group (86.0%) and 81 eyes in the control group (87.1%) were analyzed. Of 161 participants analyzed, overall mean (SD) participant age was 56.7 (10.5) years, and 100 participants (62.1%) were female. No differences were observed in arithmetic PE between the CTR and control groups in any strata. The CTR group showed smaller absolute PE in all new-generation formulas and higher percentage of PE within ±0.50 D in the Emmetropia Verifying Optical 2.0, Hoffer QST, LISA, and Pearl-DGS formulas only for eyes with an AL of 30 mm or longer compared with the control group. In traditional formulas, no differences were observed between the 2 groups in any strata.

Conclusions and relevance: In this secondary analysis, CTR implantation in highly myopic eyes did not affect the target refraction and can improve the prediction accuracy of new-generation IOL calculation formulas in eyes with AL of 30 mm or longer. These findings support use of CTR implantation in eyes with an AL of 30 mm or longer.

Trial registration: ClinicalTrials.gov Identifier: NCT05161520.

一项随机临床试验的二次分析:高度近视眼人工晶状体度数计算的荚膜张力环植入术。
重要性:人工晶状体张力环(CTR)植入术可以减少高度近视患者的人工晶状体(IOL)脱位和倾斜。然而,高度近视眼植入CTR对人工晶状体度数计算的影响尚不清楚,特别是在新一代配方中。目的:探讨CTR植入术对高度近视眼人工晶状体度数计算的影响。设计、环境和参与者:这是对2021年11月至2023年9月在中国广州中山眼科中心进行的一项随机临床试验结果的预先指定的二次分析。纳入轴向长度(AL)为26mm或以上的白内障患者,并根据AL分层分为3层(第1层:AL 26)干预:参与者根据AL分层,随机分配到每个层的CTR组(c环IOL联合CTR)或对照组(仅c环IOL)。主要观察指标:评价6个新一代配方和4个传统配方的预测结果。分析PE的算术和绝对预测误差(PE)以及PE在±0.25、±0.50 D、±0.75 D和±1.00 D范围内的眼睛百分比。结果:186名受试者共186只眼被随机分为CTR组(93只眼[50%])和对照组(93只眼[50%])。剔除1例停药病例和24只最佳矫正视力小于20/40的眼,CTR组80只眼(86.0%),对照组81只眼(87.1%)。在分析的161名参与者中,总体平均(SD)参与者年龄为56.7(10.5)岁,100名参与者(62.1%)为女性。在任何地层中,CTR组与对照组之间的算术PE均无差异。与对照组相比,CTR组在所有新一代配方中均显示出较小的绝对PE,在±0.50 D范围内,仅在AL为30 mm或更长眼睛的Emmetropia Verifying Optical 2.0、Hoffer QST、LISA和Pearl-DGS配方中的PE百分比较高。在传统公式中,两组在任何地层中均无差异。结论及意义:在本二次分析中,高度近视眼植入CTR不影响目标屈光度,可提高新一代人工晶状体计算公式在人工晶状体≥30mm眼的预测精度。这些发现支持在AL大于等于30mm的眼内植入CTR。试验注册:ClinicalTrials.gov标识符:NCT05161520。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JAMA ophthalmology
JAMA ophthalmology OPHTHALMOLOGY-
CiteScore
13.20
自引率
3.70%
发文量
340
期刊介绍: JAMA Ophthalmology, with a rich history of continuous publication since 1869, stands as a distinguished international, peer-reviewed journal dedicated to ophthalmology and visual science. In 2019, the journal proudly commemorated 150 years of uninterrupted service to the field. As a member of the esteemed JAMA Network, a consortium renowned for its peer-reviewed general medical and specialty publications, JAMA Ophthalmology upholds the highest standards of excellence in disseminating cutting-edge research and insights. Join us in celebrating our legacy and advancing the frontiers of ophthalmology and visual science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信